Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Psychometric Characteristics of the Fear of Cancer Recurrence Inventory-Severity Subscale Among Korean Cancer Survivors

  • So-Young Park (Ewha Institute for Age Integration Research, Ewha Womans University)
  • Received : 2024.02.22
  • Accepted : 2024.04.24
  • Published : 2024.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Despite the importance of choosing and using a valid assessment tool for fear of cancer recurrence (FCR) for early detection and interventions, the validity of the FCR inventory has yet to be thoroughly investigated in Korea. This study explored the psychometric properties of the Fear of Cancer Recurrence Inventory-Severity (FCRI-S) subscale and assessed its applicability to cancer survivors in Korea. Methods: The survey involved 93 Korean individuals who had survived cancer. The reliability of the FCRI-S subscale was assessed using Cronbach's α and composite reliability (CR). Confirmatory factor analysis (CFA), along with tests for discriminant and convergent validity, was conducted to evaluate the construct validity of the FCRI-S subscale. Results: The FCRI-S subscale showed excellent internal consistency (Cronbach's α=0.88; CR=0.89). CFA showed a good factor structure for the FCRI-S subscale, and the correlations of the FCRI-S subscale with FCR-related measures (r=0.69 to 0.80) and other psychosocial measures (r=-0.23 to 0.37) confirmed both the convergent and discriminant validity of the FCRI-S subscale. Conclusions: This study confirmed the robust psychometric characteristics of the FCRI-S subscale among cancer survivors in Korea. The use of the FCRI-S subscale would be helpful for health professionals to rapidly screen FCR levels in clinical settings.

Keywords

Acknowledgement

I would like to thank all the cancer survivors who participated in this study.

References

  1. Johnson Vickberg SM. Fears about breast cancer recurrence. Cancer Pract 2001;9(5):237-243. https://doi.org/10.1046/j.1523-5394.2001.009005237.x 
  2. Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology 2013;22(1):1-11. https://doi.org/10.1002/pon.3022 
  3. Savard J, Ivers H. The evolution of fear of cancer recurrence during the cancer care trajectory and its relationship with cancer characteristics. J Psychosom Res 2013;74(4):354-360. https://doi.org/10.1016/j.jpsychores.2012.12.013 
  4. Thewes B, Kaal SE, Custers JA, Manten-Horst E, Jansen R, Servaes P, et al. Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service. Support Care Cancer 2018;26(5):1479-1487. https://doi.org/10.1007/s00520-017-3975-2 
  5. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 2013;7(3):300-322. https://doi.org/10.1007/s11764-013-0272-z 
  6. Luigjes-Huizer YL, Tauber NM, Humphris G, Kasparian NA, Lam WW, Lebel S, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology 2022;31(6):879-892. https://doi.org/10.1002/pon.5921 
  7. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009;17(3):241-251. https://doi.org/10.1007/s00520-008-0444-y 
  8. Costa DS, Dieng M, Cust AE, Butow PN, Kasparian NA. Psychometric properties of the Fear of Cancer Recurrence Inventory: an item response theory approach. Psychooncology 2016;25(7):832-838. https://doi.org/10.1002/pon.4018 
  9. Lebel S, Simard S, Harris C, Feldstain A, Beattie S, McCallum M, et al. Empirical validation of the English version of the Fear of Cancer Recurrence Inventory. Qual Life Res 2016;25(2):311-321. https://doi.org/10.1007/s11136-015-1088-2 
  10. Shin J, Goo A, Ko H, Kim JH, Lim SU, Lee HK, et al. Validation study for the Korean version of Fear of Cancer Recurrence Inventory. J Korean Med Sci 2017;32(11):1792-1799. https://doi.org/10.3346/jkms.2017.32.11.1792 
  11. Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 2015;9(3):481-491. https://doi.org/10.1007/s11764-015-0424-4 
  12. Fardell JE, Jones G, Smith AB, Lebel S, Thewes B, Costa D, et al. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence. Psychooncology 2018;27(2):492-499. https://doi.org/10.1002/pon.4516 
  13. Korea Disease Control and Prevention Agency. 2022 Chronic disease trends and issue: chronic disease fact book; 2022 [cited 2024 Jan 23]. Available from: https://www.kdca.go.kr/gallery.es?mid=a20503020000&bid=0003&act=view&list_no=145880 (Korean). 
  14. Jung KW, Kang MJ, Park EH, Yun EH, Kim HJ, Kong HJ, et al. Prediction of cancer incidence and mortality in Korea, 2023. Cancer Res Treat 2023;55(2):400-407. https://doi.org/10.4143/crt.2023.448 
  15. Ministry of Health and Welfare. Five-year relative survival rate of cancer patients is 72.1% up by 6.6% in ten years; 2023 [cited 2024 Jan 23]. Available from: https://www.mohw.go.kr/board.es?mid=a20401000000&bid=0032&list_no=1479684&act=view 
  16. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer 2008;112(11 Suppl):2577-2592. https://doi.org/10.1002/cncr.23448 
  17. Pyo J, Ock M, Lee M, Kim J, Cheon J, Cho J, et al. Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study. BMC Palliat Care 2021;20(1):58. https://doi.org/10.1186/s12904-021-00749-8 
  18. Jang BY, Park JY. Subjective health status, mental health, and cancer stigma in long-term cancer survivors after gastric surgery. Asian Oncol Nurs 2018;18(2):86-93 (Korean). https://doi.org/10.5388/aon.2018.18.2.86 
  19. Park SY. The experience rate of depressive symptoms and associated factors among cancer survivors: the 2019 Korea health panel survey analyses. Ment Health Soc Work 2022;50(3):56-76 (Korean). https://doi.org/10.24301/MHSW.2022.09.50.3.56 
  20. Custers JA, van den Berg SW, van Laarhoven HW, Bleiker EM, Gielissen MF, Prins JB. The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors. Cancer Nurs 2014; 37(1):E44-E50. https://doi.org/10.1097/NCC.0b013e3182813a17 
  21. van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of blended cognitive behavior therapy for high fear of recurrence in breast, prostate, and colorectal cancer survivors: the SWORD study, a randomized controlled trial. J Clin Oncol 2017;35(19):2173-2183. https://doi.org/10.1200/JCO.2016.70.5301 
  22. Mehnert A, Herschbach P, Berg P, Henrich G, Koch U. Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF). Z Psychosom Med Psychother 2006;52(3):274-288 (German). https://doi.org/10.13109/zptm.2006.52.3.274 
  23. Heinrichs N, Zimmermann T, Huber B, Herschbach P, Russell DW, Baucom DH. Cancer distress reduction with a couple-based skills training: a randomized controlled trial. Ann Behav Med 2012;43(2):239-252. https://doi.org/10.1007/s12160-011-9314-9 
  24. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x 
  25. Han C, Jo SA, Kwak JH, Pae CU, Steffens D, Jo I, et al. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry 2008;49(2):218-223. https://doi.org/10.1016/j.comppsych.2007.08.006 
  26. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32(6):705-714. https://doi.org/10.1016/0277-9536(91)90150-B 
  27. Widhiarso W, Ravand H. Estimating reliability coefficient for multidimensional measures: a pedagogical illustration. Rev Psychol 2014;21(2):111-121. 
  28. Ferketich S. Focus on psychometrics. Aspects of item analysis. Res Nurs Health 1991;14(2):165-168. https://doi.org/10.1002/nur.4770140211 
  29. Borreani C, Alfieri S, Farina L, Bianchi E, Corradini P. Fear of cancer recurrence in haematological cancer patients: exploring socio-demographic, psychological, existential and disease-related factors. Support Care Cancer 2020;28(12):5973-5982.https://doi.org/10.1007/s00520-020-05434-9 
  30. Park IH, Kong SS. Impact of pain, depression, fear of cancer recurrence on sleep quality in cancer patients with chemotherapy. Health Welf 2022;24(3):213-238 (Korean). https://doi.org/10.23948/kshw.2022.09.24.3.213 
  31. Coutts-Bain D, Sharpe L, Pradhan P, Russell H, Heathcote LC, Costa D. Are fear of cancer recurrence and fear of progression equivalent constructs? Psychooncology 2022;31(8):1381-1389. https://doi.org/10.1002/pon.5944 
  32. Rudy L, Maheu C, Korner A, Lebel S, Gelinas C. The FCR-1: initial validation of a single-item measure of fear of cancer recurrence. Psychooncology 2020;29(4):788-795. https://doi.org/10.1002/pon.5350 
  33. Pyo J, Lee W, Choi EY, Jang SG, Ock M. Qualitative research in healthcare: necessity and characteristics. J Prev Med Public Health 2023;56(1):12-20. https://doi.org/10.3961/jpmph.22.451 
  34. Han KT, Jun JK, Im JS. National Cancer Control Plan of the Korea: current status and the fourth plan (2021-2025). J Prev Med Public Health 2023;56(3):205-211. https://doi.org/10.3961/jpmph.23.115